<?xml version="1.0" encoding="UTF-8"?><doi_batch version="4.3.7" xmlns="http://www.crossref.org/schema/4.3.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.crossref.org/schema/4.3.7 http://www.crossref.org/schema/deposit/crossref4.3.7.xsd">
		<head>
		<doi_batch_id>eamdacademy.org-uBH6-1792754487-p954738408</doi_batch_id>
		<timestamp>1792754487</timestamp>
		<depositor>
			<depositor_name>Eurasian Academy of Medicine and Dentistry</depositor_name>
			<email_address>info@eamdacademy.org</email_address>
		</depositor>
		<registrant>Eurasian Academy of Medicine and Dentistry</registrant>
	</head>
	<body>
		<journal>
			<journal_metadata>
				<full_title>Journal of Applied Pharmaceutical Technologies and Systems</full_title>
				<abbrev_title>J Appl Pharm Technol Syst</abbrev_title>
				<issn>3149-9589</issn>
			</journal_metadata>
			<journal_issue>
				<publication_date>
					<year>2026</year>
				</publication_date>
				<journal_volume>
					<volume>5</volume>
				</journal_volume>
				<issue>2</issue>
			</journal_issue>
			<journal_article publication_type="full_text">
				<titles>
					<title>Digital Batch Records as Pharmaceutical Knowledge Systems for Continuous Manufacturing and Regulatory Inspection</title>
				</titles>
								<contributors>
          					<person_name sequence="first" contributor_role="author">
            <given_name>Ivan</given_name>
            <surname>Petrov</surname>
					</person_name>
          					<person_name sequence="additional" contributor_role="author">
            <given_name>Olga</given_name>
            <surname>Ivanova</surname>
					</person_name>
          					<person_name sequence="additional" contributor_role="author">
            <given_name>Dmitry</given_name>
            <surname>Smirnov</surname>
					</person_name>
          				</contributors>
								<publication_date>
					<year>2026</year>
				</publication_date>
				<doi_data>
					<doi>10.68159/p954738408</doi>
					<resource>https://eamdacademy.org/pub/journal/3/article/p954738408</resource>
				</doi_data>
				<citation_list>
          					<citation key="rk-10.68159/p954738408-232bf109-9a69-4353-824b-1d129b4ec7be">
					  <unstructured_citation>Lawrence XY, Kopcha M. The future of pharmaceutical quality and the path to get there. Int J Pharm. 2017;528(1-2):354-9.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/p954738408-85a16d8c-0207-4b38-b58a-113d6095f837">
					  <unstructured_citation>Nasr MM, Krumme M, Matsuda Y, Trout BL, Badman C, Mascia S, et al. Regulatory perspectives on continuous pharmaceutical manufacturing: moving from theory to practice: September 26-27, 2016, international symposium on the continuous manufacturing of pharmaceuticals. J Pharm Sci. 2017;106(11):3199-206.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/p954738408-f65de438-a04f-4b4e-83f6-471dfb5673f3">
					  <unstructured_citation>Burcham CL, Florence AJ, Johnson MD. Continuous manufacturing in pharmaceutical process development and manufacturing. Annu Rev Chem Biomol Eng. 2018;9(1):253-81.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/p954738408-b6e3fe59-ddaa-43af-ab8c-7dca53c9922d">
					  <unstructured_citation>Vargas JM, Nielsen S, Cárdenas V, Gonzalez A, Aymat EY, Almodovar E, et al. Process analytical technology in continuous manufacturing of a commercial pharmaceutical product. Int J Pharm. 2018;538(1-2):167-78.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/p954738408-26e99050-c9c3-43c1-9ffb-d7abb2c48e64">
					  <unstructured_citation>Rehrl J, Karttunen AP, Nicolaï N, Hörmann T, Horn M, Korhonen O, et al. Control of three different continuous pharmaceutical manufacturing processes: Use of soft sensors. Int J Pharm. 2018;543(1-2):60-72.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/p954738408-3753bdb5-4f9d-4f45-ac4f-3a219eccef54">
					  <unstructured_citation>Arden NS, Fisher AC, Tyner K, Yu LX, Lee SL, Kopcha M. Industry 4.0 for pharmaceutical manufacturing: Preparing for the smart factories of the future. Int J Pharm. 2021;602:120554.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/p954738408-47784bad-2632-4332-b755-6d266b4fa815">
					  <unstructured_citation>Chen Y, Yang O, Sampat C, Bhalode P, Ramachandran R, Ierapetritou M. Digital twins in pharmaceutical and biopharmaceutical manufacturing: a literature review. Processes. 2020;8(9):1088.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/p954738408-2719fb63-6e37-4488-b052-af1ad26a823a">
					  <unstructured_citation>Leal F, Chis AE, Caton S, González–Vélez H, García–Gómez JM, Durá M, et al. Smart pharmaceutical manufacturing: Ensuring end-to-end traceability and data integrity in medicine production. Big Data Res. 2021;24:100172.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/p954738408-3195616d-e44c-4de5-963b-3efec579bed9">
					  <unstructured_citation>Rattan AK. Data integrity: history, issues, and remediation of issues. PDA J Pharm Sci Technol. 2018;72(2):105-16.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/p954738408-eda93e55-1b1c-4cdd-89cf-f89fef355d07">
					  <unstructured_citation>Alosert H, Savery J, Rheaume J, Cheeks M, Turner R, Spencer C, et al. Data integrity within the biopharmaceutical sector in the era of Industry 4.0. Biotechnol J. 2022;17(6):2100609.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/p954738408-d1e68389-201f-4d63-bdde-b49fffeeadd9">
					  <unstructured_citation>Su Q, Ganesh S, Moreno M, Bommireddy Y, Gonzalez M, Reklaitis GV, et al. A perspective on Quality-by-Control (QbC) in pharmaceutical continuous manufacturing. Comput Chem Eng. 2019;125:216-31.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/p954738408-1969973e-498e-4b9e-8ef3-f1b769d8f3b6">
					  <unstructured_citation>Tian G, Koolivand A, Arden NS, Lee S, O&#039;Connor TF. Quality risk assessment and mitigation of pharmaceutical continuous manufacturing using flowsheet modeling approach. Comput Chem Eng. 2019;129:106508.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/p954738408-07de9bf4-f91f-447e-8a21-2ce553f8f567">
					  <unstructured_citation>Markl D, Warman M, Dumarey M, Bergman EL, Folestad S, Shi Z, et al. Review of real-time release testing of pharmaceutical tablets: State-of-the art, challenges and future perspective. Int J Pharm. 2020;582:119353.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/p954738408-65e1532c-c900-41e9-b2ef-58227a53b831">
					  <unstructured_citation>Sacher S, Poms J, Rehrl J, Khinast JG. PAT implementation for advanced process control in solid dosage manufacturing–a practical guide. Int J Pharm. 2022;613:121408.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/p954738408-fd12dd75-dded-4d47-b6bd-7000ec153853">
					  <unstructured_citation>Badman C, Cooney CL, Florence A, Konstantinov K, Krumme M, Mascia S, et al. Why we need continuous pharmaceutical manufacturing and how to make it happen. J Pharm Sci. 2019;108(11):3521-3.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/p954738408-4f95e04b-e189-4546-ac25-a13950785843">
					  <unstructured_citation>Lipa MJ, Greene A, Calnan N. Knowledge management as a pharmaceutical quality system enabler: How enhanced knowledge transfer can help close the ICH Q10 to ICH Q12 gap. PDA J Pharm Sci Technol. 2021;75(1):64-90.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/p954738408-62e25717-e875-430b-b441-5aafb9f55c32">
					  <unstructured_citation>Hole G, Hole AS, McFalone-Shaw I. Digitalization in pharmaceutical industry: What to focus on under the digital implementation process?. Int J Pharm X. 2021;3:100095.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/p954738408-722c25d6-a480-4518-a823-855b7cdf5f48">
					  <unstructured_citation>Vanhoorne V, Vervaet C. Recent progress in continuous manufacturing of oral solid dosage forms. Int J Pharm. 2020;579:119194.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/p954738408-8aa65119-1cd4-4ce4-9173-5bb401f19703">
					  <unstructured_citation>Wahlich J. Continuous manufacturing of small molecule solid oral dosage forms. Pharmaceutics. 2021;13(8):1311.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/p954738408-06562c3d-e64a-4de9-b218-49c8fe2f71b2">
					  <unstructured_citation>Pedro F, Veiga F, Mascarenhas-Melo F. Impact of GAMP 5, data integrity and QbD on quality assurance in the pharmaceutical industry: How obvious is it?. Drug Discov Today. 2023;28(11):103759.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/p954738408-c5de4a11-4bb3-4a9f-841e-307f1c5ab7ff">
					  <unstructured_citation>Bostijn N, Van Renterghem J, Dhondt W, Vervaet C, De Beer T. A continuous manufacturing concept for a pharmaceutical oral suspension. Eur J Pharm Sci. 2018;123:576-83.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/p954738408-751530a3-3e6a-433f-89a7-84aad67bb326">
					  <unstructured_citation>Sánchez-Paternina A, Martínez-Cartagena P, Li J, Scicolone J, Singh R, Lugo YC, et al. Residence time distribution as a traceability method for lot changes in a pharmaceutical continuous manufacturing system. Int J Pharm. 2022;611:121313.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/p954738408-4849ef0a-f574-4077-9756-01b3ebe717cb">
					  <unstructured_citation>Nambiar AG, Singh M, Mali AR, Serrano DR, Kumar R, Healy AM, et al. Continuous manufacturing and molecular modeling of pharmaceutical amorphous solid dispersions. AAPS PharmSciTech. 2022;23(7):249.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/p954738408-d553be9d-b14a-46b1-90cb-16ce25becadc">
					  <unstructured_citation>Celikovic S, Rehrl J, Fraga RM, Steinberger M, Khinast J, Horn M, et al. A modern strategy for digital real-time release testing in continuous tablet manufacturing. Eur J Pharm Biopharm. 2025;211:114700.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/p954738408-139a8fac-2e69-4033-809b-a4a29e21822d">
					  <unstructured_citation>Sundarkumar V, Wang W, Mills M, Oh SW, Nagy Z, Reklaitis G. Developing a modular continuous drug product manufacturing system with real time quality Assurance for Producing Pharmaceutical Mini-Tablets. J Pharm Sci. 2024;113(4):937-47.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/p954738408-0dda06ef-7857-426b-b4bc-42178f69d767">
					  <unstructured_citation>Kakhi M, Li J, Dorantes A. Regulatory experience with continuous manufacturing and real time release testing for dissolution in new drug applications. J Pharm Sci. 2023;112(10):2604-14.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/p954738408-9a313acc-87bb-4126-9c68-c7404f58736a">
					  <unstructured_citation>O&#039;Connor TF, Chatterjee S, Lam J, de la Ossa DH, Martinez-Peyrat L, Hoefnagel MH, et al. An examination of process models and model risk frameworks for pharmaceutical manufacturing. Int J Pharm X. 2024;8:100274.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/p954738408-31fb69f3-7468-498e-8a35-60b905915cc6">
					  <unstructured_citation>Maharjan R, Kim NA, Kim KH, Jeong SH. Transformative roles of digital twins from drug discovery to continuous manufacturing: Pharmaceutical and biopharmaceutical perspectives. Int J Pharm X. 2025:100409.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/p954738408-f0dc30e7-434a-4f4f-b175-8d18b0e071fb">
					  <unstructured_citation>Gokulakrishnan D, Venkataraman S. Ensuring data integrity: Best practices and strategies in pharmaceutical industry. Intell Pharm. 2024.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/p954738408-1fbbdc5e-b504-4a55-8be3-b73862525eff">
					  <unstructured_citation>Kavasidis I, Lallas E, Leligkou HC, Oikonomidis G, Karydas D, Gerogiannis VC, et al. Deep transformers for computing and predicting ALCOA+ data integrity compliance in the pharmaceutical industry. Appl Sci. 2023;13(13):7616.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/p954738408-72455491-374e-4570-a9d6-4540a6250c90">
					  <unstructured_citation>Sharma D, Patel P, Shah M. A comprehensive study on Industry 4.0 in the pharmaceutical industry for sustainable development. Environ Sci Pollut Res. 2023;30(39):90088-98.</unstructured_citation>
											</citation>
          				</citation_list>
			</journal_article>
		</journal>
	</body>
</doi_batch>
